Resuscitative Effect of a γ-Aminobutyric Acid B Receptor Antagonist on γ-Hydroxybutyric Acid Mortality in Mice

This publication has 17 references indexed in Scilit:

• From the street to the brain: neurobiology of the recreational drug γ-hydroxybutyric acid
  Trends in Pharmacological Sciences, 2004
• Gamma Hydroxybutyric Acid (GHB) Intoxication
  Academic Emergency Medicine, 2002
• Enzyme and Receptor Antagonists for Preventing Toxicity from the Gamma‐Hydroxybutyric Acid Precursor 1,4‐Butanediol in CD‐1 Mice
  Annals of the New York Academy of Sciences, 2002
• GABAB receptor-mediated increase of neurosteroids by γ-hydroxybutyric acid
  Neuropharmacology, 2002
• Role of GABAB receptors in the sedative/hypnotic effect of γ-hydroxybutyric acid
  European Journal of Pharmacology, 2001
• Adverse Events, Including Death, Associated with the Use of 1,4-Butanediol
  New England Journal of Medicine, 2001
• Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: A case report and review of the literature
  Pediatric Emergency Care, 2000
• γ-Hydroxybutyrate is a weak agonist at recombinant GABAB receptors
  Neuropharmacology, 1999
• Binding characteristics of γ-hydroxybutyric acid as a weak but selective GABAB receptor agonist
  European Journal of Pharmacology, 1997
• The GABA B -receptor antagonist, CGP 35348, antagonises ?-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996